De Novo bone metastasis in breast cancer: tumor biology and survival outcomes in a retrospective study from Pakistan

巴基斯坦一项回顾性研究探讨了乳腺癌新发骨转移的肿瘤生物学和生存结局。

阅读:1

Abstract

PURPOSE: Breast cancer is the leading cause of cancer-related deaths among women, with 20-30% of early-stage patients eventually developing metastases, often in bones. Despite the high incidence, risk factors for de novo bone metastasis are understudied in local populations. METHODS: This single-center, retrospective study was conducted at Aga Khan University Hospital, Karachi. Patient demographics, tumor characteristics, and risk factors were assessed. Patients with de novo bone metastasis were compared to non-stage IV cases using binary univariate and multivariate logistic regression, with significance set at p < 0.05. RESULTS: Among 2565 patients, 93 (3.6%) presented with bone only metastasis (BOM) and 135 (5.3%) presented with bone and visceral metastasis together. The median age was 51 years, with females predominating. Multivariate analysis revealed that triple-negative breast carcinoma had lower odds (OR 0.36, 95% CI (0.16-0.79) p < 0.001). Advanced T and N stages and tumor grade II were linked to higher odds of bone-only metastasis. The 2-year overall survival of participants with BOM was 93% (CI: 83.7-97%). CONCLUSION: This study identifies key risk factors that provide the basis for early detection and intervention strategies. While it has a few limitations, these findings can guide future research and inform risk assessment models for more diverse populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。